Goldman Sachs’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $40.6M | Buy |
|
|||||
|
2025
Q2 | $40.9M | Buy |
|
|||||
|
2025
Q1 | $19.8M | Buy |
|
|||||
|
2024
Q4 | $12.7M | Sell |
|
|||||
|
2024
Q3 | $19M | Sell |
|
|||||
|
2024
Q2 | $18.4M | Buy |
|
|||||
|
2024
Q1 | $14.9M | Sell |
|
|||||
|
2023
Q4 | $14.3M | Buy |
|
|||||
|
2023
Q3 | $31.2M | Buy |
|
|||||
|
2023
Q2 | $9.76M | Sell |
|
|||||
|
2023
Q1 | $8.54M | Buy |
|
|||||
|
2022
Q4 | $10.2M | Sell |
|
|||||
|
2022
Q3 | $72.1M | Buy |
|
|||||
|
2022
Q2 | $0 | Buy |
|
|||||
|
2022
Q1 | $15.5M | Sell |
|
|||||
|
2021
Q4 | $37.4M | Buy |
|
|||||
|
2021
Q3 | $697K | Buy |
|
|||||
|
2021
Q2 | $709K | Sell |
|
|||||
|
2021
Q1 | $6.08M | Sell |
|
|||||
|
2020
Q4 | $6.44M | Buy |
|
|||||
|
2020
Q3 | $1.9M | Sell |
|
|||||
|
2020
Q2 | $1.76M | Buy |
|
|||||
|
2020
Q1 | $1.16M | Buy |
|
|||||
|
2019
Q4 | $819K | Buy |
|
|||||
|
2019
Q3 | $594K | Sell |
|
|||||
|
2019
Q2 | $1.11M | Buy |
|